145 related articles for article (PubMed ID: 36282324)
1. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
Tagarro A; Domínguez-Rodríguez S; Mesa JM; Epalza C; Grasa C; Iglesias-Bouzas MI; Fernández-Cooke E; Calvo C; Villaverde S; Torres-Fernández D; Méndez-Echevarria A; Leoz I; Fernández-Pascual M; Saavedra-Lozano J; Soto B; Aguilera-Alonso D; Rivière JG; Fumadó V; Martínez-Campos L; Vivanco A; Pilar-Orive FJ; Alcalá P; Ruiz B; López-Machín A; Oltra M; Moraleda C;
Eur J Pediatr; 2023 Jan; 182(1):461-466. PubMed ID: 36282324
[TBL] [Abstract][Full Text] [Related]
2. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
3. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
4. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
[TBL] [Abstract][Full Text] [Related]
5. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
[TBL] [Abstract][Full Text] [Related]
8. Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021.
Shah AB; Abrams JY; Godfred-Cato S; Kunkel A; Hammett TA; Perez MA; Hsiao HM; Baida N; Rostad CA; Ballan W; Ede K; Laham FR; Kao CM; Oster ME; Belay ED
Pediatr Infect Dis J; 2023 Nov; 42(11):990-998. PubMed ID: 37862698
[TBL] [Abstract][Full Text] [Related]
9. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India.
Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK;
Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study.
Channon-Wells S; Vito O; McArdle AJ; Seaby EG; Patel H; Shah P; Pazukhina E; Wilson C; Broderick C; D'Souza G; Keren I; Nijman RG; Tremoulet A; Munblit D; Ulloa-Gutierrez R; Carter MJ; Ramnarayan P; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Blyuss O; Levin M;
Lancet Rheumatol; 2023 Apr; 5(4):e184-e199. PubMed ID: 36855438
[TBL] [Abstract][Full Text] [Related]
11. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
[TBL] [Abstract][Full Text] [Related]
12. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
[TBL] [Abstract][Full Text] [Related]
13. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults.
Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB
Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin for the treatment of childhood encephalitis.
Iro MA; Martin NG; Absoud M; Pollard AJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P
Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Therapy for MIS-C.
Ouldali N; Son MBF; McArdle AJ; Vito O; Vaugon E; Belot A; Leblanc C; Murray NL; Patel MM; Levin M; Randolph AG; Angoulvant F;
Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37376963
[TBL] [Abstract][Full Text] [Related]
19. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.
Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y
Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam.
Phung NTN; Tran TT; Nguyen TH; Nguyen TH; Nguyen TMT
Pediatr Neonatol; 2022 Nov; 63(6):569-574. PubMed ID: 35871994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
